#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	4044	16S	1529	1529	100.0	16S.l6.c30.ctg.1	2203	532.3	1	SNP	n	C1184T	0	.	.	1184	1184	C	1460	1460	C	601	C,T	501,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6574	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4043	486.8	0	.	n	.	0	T695C	SNP	695	695	T	1248	1248	C	514	C,G	424,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6574	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4043	486.8	0	.	n	.	0	G1337A	SNP	1337	1337	G	1890	1890	A	609	A,G	526,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6574	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4043	486.8	0	.	n	.	0	T1971C	SNP	1971	1971	T	2524	2524	C	570	C	483	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6574	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4043	486.8	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	3150	3150	T	573	T,C	486,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	6574	23S	2890	2890	99.86	23S.l15.c4.ctg.1	4043	486.8	1	SNP	n	A2045G	0	.	.	2045	2045	A	2598	2598	A	599	A	502	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_P_01364c	folP.WHO_P_01364c	1	1	27	680	folP	852	852	100.0	folP.l6.c4.ctg.1	1966	103.5	1	SNP	p	R228S	1	.	.	682	684	AGC	1274	1276	AGC	149;151;152	A,G;G;C	133,1;134;138	folP.WHO_P_01364c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1370	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3754	109.0	1	SNP	p	S91F	0	.	.	271	273	TCC	736	738	TCC	127;126;126	T;C;C	103;104;106	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1370	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3754	109.0	1	SNP	p	D95G	0	.	.	283	285	GAC	748	750	GAC	126;124;123	G;A;C	102;105;100	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1370	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3754	109.0	1	SNP	p	D95N	0	.	.	283	285	GAC	748	750	GAC	126;124;123	G;A;C	102;105;100	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	554	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1729	95.7	0	.	p	.	0	A39T	NONSYN	115	117	GCC	715	717	ACC	148;149;147	A;C;C	130;129;130	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	554	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1729	95.7	0	.	p	.	0	R44H	NONSYN	130	132	CGC	730	732	CAC	144;146;148	C;A;C,G	123;124;121,1	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	554	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1729	95.7	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	913	915	CAC	155;157;157	C;A;C	140;145;148	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	554	mtrR	633	633	99.21	mtrR.l6.c4.ctg.1	1729	95.7	1	SNP	p	G45D	0	.	.	133	135	GGC	733	735	GGC	148;147;148	G;G;C	128;124;128	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	410	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1477	83.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1466	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3203	136.6	1	SNP	p	D86N	0	.	.	256	258	GAC	685	687	GAC	164;163;164	G;A;C	141;135;142	parC.WHO_P_00203c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1466	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3203	136.6	1	SNP	p	S87I	0	.	.	259	261	AGT	688	690	AGT	164;163;163	A;G;T,G	138;143;140,1	parC.WHO_P_00203c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1466	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3203	136.6	1	SNP	p	S87W	0	.	.	259	261	AGT	688	690	AGT	164;163;163	A;G;T,G	138;143;140,1	parC.WHO_P_00203c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1466	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3203	136.6	1	SNP	p	S87R	0	.	.	259	261	AGT	688	690	AGT	164;163;163	A;G;T,G	138;143;140,1	parC.WHO_P_00203c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_P_00203c	parC.WHO_P_00203c	1	1	27	1466	parC	2304	2304	100.0	parC.l6.c4.ctg.1	3203	136.6	1	SNP	p	S88P	0	.	.	262	264	TCC	691	693	TCC	163;164;166	T;C;C	142;140;145	parC.WHO_P_00203c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1122	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3173	106.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1842	1844	GGC	139;137;136	G;G,C,A;C	113;117,1,1;114	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	986	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2772	105.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1479	1481	GCA	150;150;149	G,A;C,A;A	126,1;126,1;128	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	986	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2772	105.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1482	1484	ATC	149;149;149	A;T;C,T,G	130;128;123,1,1	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	986	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2772	105.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1494	1496	GTG	145;145;145	G;T;G	126;126;127	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	986	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2772	105.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1494	1496	GTG	145;145;145	G;T;G	126;126;127	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	986	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2772	105.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1998	2000	ACC	97;97;97	A,C;C;C	84,2;83;81	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	986	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2772	105.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2052	2054	GCG	96;95;95	G;C;G,A	81;76;78,1	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	986	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2772	105.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2052	2054	GCG	96;95;95	G;C;G,A	81;76;78,1	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	986	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2772	105.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2175	2177	GGC	100;101;100	G;G,C;C	89;91,1;89	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	986	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2772	105.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2184	2186	GGC	100;99;99	G;G;C,T	88;88;87,1	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	986	penA	1749	1749	100.0	penA.l6.c4.ctg.1	2772	105.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2202	2204	CCG	96;97;97	C;C;G	79;86;79	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1480	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3419	129.6	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1842	1844	CTG	146;146;146	C,T,A;T,G;G,T	117,2,1;115,1;111,1	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	734	porA	1146	1146	99.83	porA.l15.c4.ctg.1	2281	96.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	791	791	C	108	C	95	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	696	porB1b	1047	1047	95.64	porB1b.l15.c4.ctg.1	1878	109.3	0	.	p	.	0	G38E	NONSYN	112	114	GGA	604	606	GAA	151;152;151	G;A;A,C	130;130;130,2	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	696	porB1b	1047	1047	95.64	porB1b.l15.c4.ctg.1	1878	109.3	0	.	p	.	0	A109V	NONSYN	325	327	GCC	817	819	GTC	154;154;154	G;T,G;C	126;129,2;128	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	696	porB1b	1047	1047	95.64	porB1b.l15.c4.ctg.1	1878	109.3	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	883	885	TAT	153;152;152	T;A;T	133;129;122	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	696	porB1b	1047	1047	95.64	porB1b.l15.c4.ctg.1	1878	109.3	0	.	p	.	0	N134E	NONSYN	400	402	AAT	892	894	GAG	147;146;145	G,T;A;G,A	125,1;125;122,1	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	696	porB1b	1047	1047	95.64	porB1b.l15.c4.ctg.1	1878	109.3	0	.	p	.	0	V135L	NONSYN	403	405	GTG	895	897	CTT	145;145;149	C,A;T;T	126,1;121;123	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	696	porB1b	1047	1047	95.64	porB1b.l15.c4.ctg.1	1878	109.3	0	.	p	.	0	G140K	NONSYN	418	420	GGA	910	912	AAA	142;142;141	A,C;A;A	120,1;118;121	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	696	porB1b	1047	1047	95.64	porB1b.l15.c4.ctg.1	1878	109.3	0	.	p	.	0	K143G	NONSYN	427	429	AAA	919	921	GGA	141;141;142	G,C;G;A	121,1;119;121	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	696	porB1b	1047	1047	95.64	porB1b.l15.c4.ctg.1	1878	109.3	0	.	p	.	0	V151A	NONSYN	451	453	GTA	943	945	GCA	146;150;149	G;C;A	127;126;127	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	696	porB1b	1047	1047	95.64	porB1b.l15.c4.ctg.1	1878	109.3	0	.	p	.	0	D171G	NONSYN	511	513	GAC	1003	1005	GGT	148;147;147	G;G,T;T	123;122,1;120	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	696	porB1b	1047	1047	95.64	porB1b.l15.c4.ctg.1	1878	109.3	0	.	p	.	0	Q187R	NONSYN	559	561	CAA	1051	1053	CGA	147;145;144	C,A;G;A	124,1;125;123	.	.
porB1b.WHO_Z_02266c	porB1b.WHO_Z_02266c	1	1	539	696	porB1b	1047	1047	95.64	porB1b.l15.c4.ctg.1	1878	109.3	0	.	p	.	0	Y211fs	FSHIFT	631	631	T	1123	1123	T	137	T	122	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2724	rpoB	4179	4179	100.0	rpoB.l6.c17.ctg.1	5164	157.5	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2197	2199	AAT	152;151;150	A,G;A;T,G	125,1;130;125,1	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	374	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1396	79.9	1	SNP	p	V57M	1	.	.	169	171	ATG	629	631	ATG	143;143;143	A;T;G	122;125;125	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
